Literature DB >> 639818

ABH-blood-group antigens and glycolipids of human saliva.

B L Slomiany, A Slomiany.   

Abstract

The nature of ABH-blood-group antigens in saliva was investigated. Human saliva was examined serologically for ABH-blood-group activity in its native form and after various treatments. The activity of the native form persisted in the delipidated samples, but was entirely lost after alkaline degradation. The lipid portion of saliva was completely inactive in the ABH hemagglutination inhibition system. The same results were obtained when purified glycolipid fraction of saliva was used instead of whole lipid extract. Neither alkaline treatment nor excessive amounts of salivary lipids effected antigenic activity of A-active glycosphingolipids of hog gastric mucosa admixed to saliva samples before alkaline degradation and/or in presence of large amounts of salivary lipids. The isolated glycolipid fractions contained at least eight glycolipids, each of which was composed of glucose, glyceryl ethers and fatty acids and differed from others with respect to number of glucose residues. Sphingosine and sugar residues involved in formation of ABH antigenic determinants were not detected. These findings together with data on stomach secretion [1,2] led us to the conclusion that ABH-blood-group antigens of saliva are exclusively of glycoprotein nature.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 639818     DOI: 10.1111/j.1432-1033.1978.tb12233.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  6 in total

1.  Streptococcus mutans dextransucrase: stimulation by phospholipids from human sera and oral fluids.

Authors:  C F Schachtele; S K Harlander; J W Bracke; L C Ostrum; J A Maltais; R J Billings
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

2.  Blood group antigen loci demonstrate multivariate genetic associations with circulating cellular adhesion protein levels in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Nicholas B Larson; Paul A Decker; Christina L Wassel; James S Pankow; Weihong Tang; Naomi Q Hanson; Michael Y Tsai; Suzette J Bielinski
Journal:  Hum Genet       Date:  2016-02-16       Impact factor: 4.132

3.  Higher frequency of secretor phenotype in O blood group - its benefits in prevention and/or treatment of some diseases.

Authors:  Mohamad Salih Jaff
Journal:  Int J Nanomedicine       Date:  2010-11-02

4.  Blood Group Antigen Recognition via the Group A Streptococcal M Protein Mediates Host Colonization.

Authors:  David M P De Oliveira; Lauren Hartley-Tassell; Arun Everest-Dass; Christopher J Day; Rebecca A Dabbs; Thomas Ve; Bostjan Kobe; Victor Nizet; Nicolle H Packer; Mark J Walker; Michael P Jennings; Martina L Sanderson-Smith
Journal:  mBio       Date:  2017-01-24       Impact factor: 7.867

5.  Carbohydrate Ligands for COVID-19 Spike Proteins.

Authors:  Yung-Kuo Lee; Wen-Chiu Chang; Ekambaranellore Prakash; Yu-Ju Peng; Zhi-Jay Tu; Chun-Hung Lin; Pang-Hung Hsu; Chuan-Fa Chang
Journal:  Viruses       Date:  2022-02-06       Impact factor: 5.048

6.  The exploitation of human glycans by Group A Streptococcus.

Authors:  Anuk D Indraratna; Arun Everest-Dass; Danielle Skropeta; Martina Sanderson-Smith
Journal:  FEMS Microbiol Rev       Date:  2022-05-06       Impact factor: 15.177

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.